A prospective, multi-institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cells.


CONTEXT The fraction of malignant cells in tumor tissue submitted for tests of genetic alterations is a critical variable in testing accuracy. That fraction is currently determined by pathologist visual estimation of the percentage of malignant cells. Inaccuracy could lead to a false-negative test result. OBJECTIVE To describe a prospective, multi… (More)
DOI: 10.5858/arpa.2012-0561-CP

3 Figures and Tables


  • Presentations referencing similar topics